Vissers‐Bodmer syndrome caused by a novel de novo CNOT1 frameshift variant
Authors:
- 11 October 2023
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (2) , 363-367
Abstract
Vissers‐Bodmer Syndrome (VIBOS) is an autosomal dominant disorder caused by variants in the CNOT1 gene. It is characterized by systemic developmental and language‐motor delay, intellectual disabilities, growth and behavioral abnormalities, hypotonia, and distal skeletal defects, such as deformities of the hands and feet. This syndrome becomes evident during infancy and can display a highly variable phenotype. Thirty‐nine individuals with heterozygous de novo CNOT1 variants were first reported in 2019. Herein, we report a child with VIBOS who exhibited delayed motor development for over 4 years, along with hypotonia and atypical facial features. Notably, the patient developed short stature as the primary characteristic without any intellectual disability or organic nervous system lesions. Genetic testing revealed a de novo base duplication variant in exon 5 of the CNOT1 gene, NM_016284.5( CNOT1 ):c.316_317dup(p.Pro107Serfs*10). Importantly, the pathogenicity of this specific variant has not been reported in relevant literature. This study reports a new variant, thereby enriching the variant spectrum of CNOT1 associated with VIBOS, and contributes to the genetic counseling of affected families.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2021JJ70137)
This publication has 8 references indexed in Scilit:
- Fetal Description of the Pancreatic Agenesis and Holoprosencephaly Syndrome Associated to a Specific CNOT1 VariantPediatric and Developmental Pathology, 2022
- Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in childrenGrowth Hormone & IGF Research, 2020
- De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental DelayThe American Journal of Human Genetics, 2020
- Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysisEndocrine, 2019
- The central region of CNOT1 and CNOT9 stimulates deadenylation by the Ccr4–Not nuclease moduleBiochemical Journal, 2018
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short StatureYonsei Medical Journal, 2014
- Distinct expression patterns of the subunits of the CCR4–NOT deadenylase complex during neural developmentBiochemical and Biophysical Research Communications, 2011